Navigation Links
Urocidin™ Phase III Clinical Trial Results to be Presented at EAU and AUA Conferences
Date:2/17/2011

CHADDS FORD, Pa. and BELLEVILLE, Ontario, Feb. 17, 2011 /PRNewswire/ -- Endo Pharmaceuticals (Nasdaq: ENDP) and Bioniche Life Sciences Inc. (TSX and ASX: BNC) today announced plans for peer-reviewed presentation of interim efficacy and safety results from the first Phase III trial of the intravesical formulation of Mycobacterial cell wall-DNA complex (MCC), known as Urocidin™ or EN3348. The results to be presented have been generated from an ongoing Phase III registration trial with Urocidin™ in the treatment of non-muscle-invasive bladder cancer (NMIBC) that is refractory to current first-line therapy (Bacillus Calmette-Guerin, known as BCG).

The first abstract and poster summaries of such results will be made available during the Annual Congress of the European Association of Urology (EAU) March 18-22 in Vienna, Austria. The accepted abstract is now available to EAU members. Further disclosure of results from this trial will be made during a podium presentation at the annual American Urological Association (AUA) meeting May 14-19 in Washington, D.C.

Phase III Results

The EAU and AUA abstracts highlight results based on an interim analysis of the Phase III trial.  The objective of the trial is to evaluate the efficacy and safety of Urocidin™ in patients with non-muscle-invasive bladder cancer (NMIBC) who are refractory to intravesical BCG therapy and at high risk of progression. A total of 129 patients were enrolled from 25 centers in the U.S. and Canada, with high grade papillary and/or carcinoma in situ (CIS) and having failed to respond to one or more courses of BCG. The overall one-year disease-free survival (DFS) rate was 25 percent. DFS is defined as lack of recurrence or progression to muscle-invasive disease, as confirmed by biopsy.  The one-year DFS rates, when sub-divided by tumor type (e
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... NEW YORK and SAN JOSE, Calif. ... Systems has been named as a laureate of The ... recognized for applying technology to benefit humanity and spark global ... Museum of Innovation, and presented by Applied Materials, Inc., selected ... Award category. Photo - http://photos.prnewswire.com/prnh/20140917/146680 ...
(Date:9/17/2014)... 17, 2014  Lightbeam Health Solutions announced today ... (Physician Direct ACO) to deploy the Lightbeam population ... better care while reducing costs. Photo ... Direct Accountable Care Organization is the ACO operating ... OPNS mission is to be the premier integrated ...
(Date:9/17/2014)... , Sept. 17, 2014 An analysis ... regarding patients taking Sovaldi® (sofosbuvir), a new and expensive ... shows that over the last several months (May through ... downward trend in Sovaldi utilization. This suggests another surge ... new therapeutic regimens of similar efficacy and shorter duration ...
Breaking Medicine Technology:Gradian Health Systems Named A 2014 Laureate of The Tech Awards 2Gradian Health Systems Named A 2014 Laureate of The Tech Awards 3Physician Direct Accountable Care Organization Selects Lightbeam Health to Enable Better Care at a Lower Cost 2Physician Direct Accountable Care Organization Selects Lightbeam Health to Enable Better Care at a Lower Cost 3CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies 2CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies 3CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies 4
(Date:9/17/2014)... Boston Children’s Museum and From ... concert series, introducing young Museum visitors to musicians ... premier national platform celebrating the stories, talents, and ... young musicians featured will also be showcased on ... is fortunate to partner with the wonderful musicians ...
(Date:9/17/2014)... 17, 2014 A petition to ban ... laparoscopic hysterectomies and other gynecological surgeries has gathered nearly ... posted on Change.org, at least 84,908 supporters had signed ... to a recent report from ABC News, the Change.org ... Hooman Noorchashm, after his wife, Dr. Amy Reed, was ...
(Date:9/17/2014)... (HealthDay News) -- Present-day Europeans are the descendants ... according to a new study. Previous ... and early European farmers. But, a new genetic ... also the descendants of Ancient North Eurasians. Nearly ... third ancestral group, researchers from Harvard Medical School ...
(Date:9/17/2014)... is not properly designed to meet the needs of ... their families, and major changes to the system are ... Medicine. The 21-member committee that wrote the report ... medical care and social services and that is high-quality, ... "advance care planning" for end-of-life by individuals, for improved ...
(Date:9/17/2014)... 2014 Mercy “topped out” the world’s ... final beam into place. Sister of Mercy Claudia Ward ... (Photos and video of the event, including footage from ... http://bit.ly/MercyVirtual .) , “The topping out means we ... to thousands of patients regardless of the hour or ...
Breaking Medicine News(10 mins):Health News:Boston Children's Museum Partners with From the Top to Offer Monthly Concert Series 2Health News:Boston Children's Museum Partners with From the Top to Offer Monthly Concert Series 3Health News:Power Morcellator Petition Nears 85,000 Signatures, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Petition Nears 85,000 Signatures, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Petition Nears 85,000 Signatures, Bernstein Liebhard LLP Reports 4Health News:Europeans Are Descendants of at Least 3 Ancient Human Groups: Study 2Health News:Europeans Are Descendants of at Least 3 Ancient Human Groups: Study 3Health News:US health system not properly designed to meet needs of patients nearing end of life, says IOM 2Health News:US health system not properly designed to meet needs of patients nearing end of life, says IOM 3Health News:US health system not properly designed to meet needs of patients nearing end of life, says IOM 4Health News:US health system not properly designed to meet needs of patients nearing end of life, says IOM 5Health News:Mercy Tops Out World's First Virtual Care Center 2
... Flu Granted Conditional License by USDA , ... Health, the global leader in veterinary biologicals, today ... canine influenza virus (CIV), which was granted a ... Department of Agriculture (USDA) on May ...
... ,Kidney Walk, At Soldier Field , , MOUNTAIN VIEW, ... first and leading providers of kidney dialysis services and a ... the National Kidney Foundation (NKF) of Illinois, Kidney Walk in ... will be held Sunday, June 28, 2009 at Soldier Field ...
... , , , Teva Pharmaceuticals Hosting Second ... Campaign , , CHICAGO, June 23 According ... of three people in Illinois under the age of 65 ... awareness to the healthcare issues facing everyday Americans, on June ...
... Philadelphia Opens Free-Standing Inpatient Unit , ... These are the adjectives Hospice of Philadelphia considered when it developed ... patient in their own home is ideal, but is not always ... hospital. The new hospice unit provides patients and their families ...
... and NEW YORK, June 23 The ... the American University of Beirut Medical Center ... The Magnet program recognizes nursing excellence "in the ... services in an environment that supports professional nursing practice, ...
... a new breast biopsy technique that could lead to ... according to a study performed at Roberts Research Institute, ... Centre, London, ON, Canada. The new technique uses a ... and has a braking system to allow for accurate ...
Cached Medicine News:Health News:New Vaccine from Intervet/Schering-Plough Animal Health is First for Canine Influenza Virus 2Health News:New Vaccine from Intervet/Schering-Plough Animal Health is First for Canine Influenza Virus 3Health News:New Vaccine from Intervet/Schering-Plough Animal Health is First for Canine Influenza Virus 4Health News:Satellite Healthcare Supports Kidney Wellness in Chicago 2Health News:Businesses, Community Leaders Invited to Come Together to Examine the Rising Cost of Healthcare 2Health News:Unique Facility Designed for the Comfort of Hospice Patients and Their Families 2Health News:Unique Facility Designed for the Comfort of Hospice Patients and Their Families 3Health News:AUB Medical Center Designated First 'Magnet' Facility in the Middle East 2Health News:AUB Medical Center Designated First 'Magnet' Facility in the Middle East 3
... This direct-acting inserter grasps the thinnest portion ... resulting in a minimum incision requirement. The ... the thicker center of the optic and ... resulting in delivery of an implant through ...
... inserter allows insertion of AMO SI-30 and SI-40 ... millimeters, and is perfect for clear corneal and ... has highly polished 6.5 millimeter rounded blades for ... tips of the blades have a .15 millimeter ...
... KR-8000PA Supra Auto-Kerato Refractometer combines an auto-refractor, ... mapping system all in a single, compact ... three times the diagnostic capabilities in one-third ... cost of the individual instruments. By implementing ...
Neomycin and Polymyxin B Sulfates and Hydrocortisone ophthalmic suspension is a sterile antimicrobial and anti-inflammatory suspension for ophthalmic use....
Medicine Products: